BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260328
DTSTAMP:20260408T011647
CREATED:20251204T144747Z
LAST-MODIFIED:20251204T144808Z
UID:10000447-1774396800-1774655999@oncodaily.com
SUMMARY:2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules
DESCRIPTION:The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27\, 2026\, in a hybrid format with options to attend in Tucson\, Arizona\, or virtually. \nOrganized by the Society for Immunotherapy of Cancer (SITC)\, the program will bring together experts in cell therapy\, drug development\, and immuno-oncology to focus on the timely topic of combining next-generation immuno-oncology agents with cellular therapies to treat cancer. \nThe organizing com \nmittee includes Kristen Hege\, MD\, Gordon Moody\, MS\, Daniel Powell\, Jr.\, PhD\, and Evan Weber\, PhD\, and registration for the event opens on August 18\, 2025. \nRegister. \nAbstract Submission.
URL:https://oncodaily.com/event/sitc-spring-scientific-421396
LOCATION:El Conquistador Tucson\, A Hilton Resort\, 10000 N Oracle Rd\, Tucson\, AZ\, 85704\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/1752526849650.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260318T130000
DTEND;TZID=America/Halifax:20260318T160000
DTSTAMP:20260408T011647
CREATED:20260312T123946Z
LAST-MODIFIED:20260312T123946Z
UID:10000691-1773838800-1773849600@oncodaily.com
SUMMARY:2026 SITC Autoimmunity and Immuno-Oncology Virtual Summit
DESCRIPTION:The Society for Immunotherapy of Cancer (SITC) will host the free\, open-door 2026 Virtual Summit on Autoimmunity and Immuno-Oncology on Wednesday\, March 18\, 2026\, from 1–4 p.m. EDT\, featuring program organizers Samik Basu (Cabaletta Bio)\, Marco Ruella (University of Pennsylvania)\, and Huji Xu (Naval Medical University and Tsinghua University) to highlight the emerging role of immunotherapies in treating autoimmune diseases. Expert faculty will provide an overview of the current state of knowledge\, mechanisms of toxicity\, and management strategies across different patient populations to foster collaboration between the immuno-oncology and rheumatology fields. \nRegister.
URL:https://oncodaily.com/event/immuno-oncology-467880
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-12T163714.279.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260216
DTEND;VALUE=DATE:20260219
DTSTAMP:20260408T011647
CREATED:20251204T143844Z
LAST-MODIFIED:20251204T143910Z
UID:10000446-1771200000-1771459199@oncodaily.com
SUMMARY:SCION Workshop 2026
DESCRIPTION:The SITC Clinical Immuno-Oncology Network (SCION) Workshop is an intimate\, intensive clinical trial development program organized by the Society for Immunotherapy of Cancer (SITC)\, designed to address the unique challenges in designing protocols specific to cancer immunotherapy. \nThe 2026 SCION Workshop is scheduled for February 16-18\, 2026\, and will be held at The Westin Copley Place\, Boston. Participation requires an application with a proposed protocol abstract and includes a mandatory 90-day post-workshop report to ensure progress in clinical trial development.
URL:https://oncodaily.com/event/scion-421390
LOCATION:The Westin Copley Place\, Boston\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/16_9-1.jpg
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260119
DTSTAMP:20260408T011647
CREATED:20251206T181422Z
LAST-MODIFIED:20251206T181441Z
UID:10000459-1768521600-1768780799@oncodaily.com
SUMMARY:Cancer Immunotherapy Winter School 2026
DESCRIPTION:The Cancer Immunotherapy Winter School\, hosted by the Society for Immunotherapy of Cancer (SITC)\, is a hybrid program taking place in Boston and virtually from February 16–18\, 2026\, with the in-person meeting held at The Westin Copley Place\, Boston. \nThe school is tailored for early-to-mid career scientists and clinicians who are new to the field\, providing intensive education from leading experts. The curriculum offers separate clinical and research tracks that cover the fundamental principles of tumor immunology\, cancer immunotherapy\, and developing areas such as biomarker technology\, clinical trial design\, and considerations for combination therapies. Travel awards are available\, and Continuing Education Credits are planned for the program. \nRegister.
URL:https://oncodaily.com/event/cancer-immunotherapy-winter-school-422970
LOCATION:The Westin Copley Place\, Boston\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/CIWS.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251217T130000
DTEND;TZID=America/Halifax:20251217T141500
DTSTAMP:20260408T011647
CREATED:20251206T173920Z
LAST-MODIFIED:20251206T173950Z
UID:10000456-1765976400-1765980900@oncodaily.com
SUMMARY:SITC Webinar on Bispecifics and T Cell Engagers: Practical Strategies for Recognizing and Managing Toxicities
DESCRIPTION:The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual\, multi-stakeholder event scheduled for December 17\, 2025\, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty\, including Sid Devarakonda\, MD\, and Megan May\, PharmD\, to provide clinical insights into the use of bispecifics and T cell engagers and the necessary management of their associated toxicity. \nThe primary focus is on identifying and employing best practices for treating immune-related adverse events (irAEs)\, particularly Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)\, with the goal of improving patient outcomes through multidisciplinary and collaborative approaches. \nRegister.
URL:https://oncodaily.com/event/bispecifics-and-t-cell-engagers-422941
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/sitc.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260408T011647
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251205T150000
DTEND;TZID=America/Halifax:20251205T180000
DTSTAMP:20260408T011647
CREATED:20251203T224622Z
LAST-MODIFIED:20251203T224638Z
UID:10000438-1764946800-1764957600@oncodaily.com
SUMMARY:SITC-ASH Scientific Workshop on Host Factors in Cell and Gene Therapy: Impact on Efficacy and Toxicity
DESCRIPTION:The SITC-ASH Scientific Workshop on Host Factors in Cell and Gene Therapy: Impact on Efficacy and Toxicity is a collaborative scientific workshop organized by the American Society of Hematology (ASH) and the Society for Immunotherapy of Cancer (SITC). \nScheduled for Friday\, December 5\, 2025\, from 3:00–6:00 p.m. ET\, the workshop will be held in conjunction with the ASH Annual Meeting at the Orange County Convention Center in Orlando\, Florida. The program focuses on how host biology influences the efficacy and toxicity of cell and gene therapies\, with expert speakers sharing recent findings and discussing strategies to optimize outcomes for both hematologic and solid tumor applications. \nRegister.
URL:https://oncodaily.com/event/sitc-ash-421177
LOCATION:Orange County Convention Center\, 9860 Universal Blvd\, Orlando\, FL\, 32819-8706\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Image-10-1.webp
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251105
DTEND;VALUE=DATE:20251110
DTSTAMP:20260408T011647
CREATED:20251102T215427Z
LAST-MODIFIED:20251102T215452Z
UID:10000307-1762300800-1762732799@oncodaily.com
SUMMARY:SITC 2025
DESCRIPTION:The Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting and Pre-Conference Programs marks the organization’s 40th Anniversary\, celebrating four decades of driving breakthroughs in cancer immunotherapy. The event will take place from November 5–9\, 2025\, with Pre-Conference Programs held on November 5–6 and the Annual Meeting running from November 7–9. The Meeting provides a multidisciplinary\, educational environment focused on improving outcomes for cancer patients by integrating strategies based on basic and applied cancer immunotherapy research\, including sessions on Artificial Intelligence (AI)\, radiomics\, the microbiome\, and Antibody-Drug Conjugates (ADCs). \nYou can find more posts featuring SITC on OncoDaily.
URL:https://oncodaily.com/event/sitc-402220
LOCATION:Gaylord National Resort & Convention Center\, 201 Waterfront St\, National Harbor\, MD\, 20745\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/SITC.jpg
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
END:VCALENDAR